Heyman Richard A. sold ORIC
July 6, 2026 · Form 4 insider transaction
Heyman Richard A. sold 300 shares of ORIC Pharmaceuticals, Inc. at $12.00 per share, a transaction worth $3.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$12.00
Total value
$3.6K
InsiderHeyman Richard A.
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after212,772
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.; The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.